PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Apr-2026 AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 Businesswire
01-Apr-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Apr-2026 VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet ACCESS Newswire
01-Apr-2026 CORE Industrial Partners Completes the Sale of PrecisionX Group Businesswire
01-Apr-2026 Windjammer Capital Acquires PrecisionX Group Businesswire
01-Apr-2026 Cvent Closes Acquisition of ON24 Businesswire
01-Apr-2026 Charles River Associates (CRA) Promotes 11 to Vice President, Strengthening Expertise Across the Firm Businesswire
01-Apr-2026 Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development Businesswire
01-Apr-2026 Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development Businesswire
01-Apr-2026 TRNR Publishes Q4 & Year-End 2025 Shareholder Letter Discussing Record Results & Expectations for 2026 Given Company Transformation ACCESS Newswire
01-Apr-2026 Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader Businesswire
01-Apr-2026 Ray Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RTx-015 in Retinitis Pigmentosa Businesswire
01-Apr-2026 Voro Therapeutics to Present New Preclinical Data on PrimeBody™ Platform and VOR-101 at Upcoming AACR 2026 and AET Europe Conferences Businesswire
01-Apr-2026 Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026 Businesswire
01-Apr-2026 Landmark Bio Secures Up to $18.3 Million ARPA-H Award to Build a Scalable Continuous Manufacturing Platform for Extracellular Vesicle Therapies Businesswire
01-Apr-2026 Nocion Therapeutics Strengthens Board of Directors with Appointment of Mark Iwicki Businesswire
01-Apr-2026 bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 Businesswire
01-Apr-2026 Orca Bio Announces FDA Review Extension of BLA for Orca-T for the Treatment of Hematologic Malignancies Businesswire
01-Apr-2026 Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States Businesswire
01-Apr-2026 Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement Businesswire